Mc Glone Suttner Wealth Management, Inc. Amgen Inc Transaction History

Mc Glone Suttner Wealth Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$262.75 - $319.31 $206,521 - $250,977	786 New	786 $226 Million
Q4 2023 Jan 18, 2024	SELL	$255.7 - $288.46 $4,602 - $5,192	-18 Reduced 2.24%	786 $226 Million
Q3 2023 Oct 19, 2023	BUY	$218.65 - $271.46 $175,794 - $218,253	804 New	804 $216 Million
Q4 2022 Feb 09, 2023	BUY	$229.03 - $291.01 $256,513 - $325,931	1,120 New	1,120 $294 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Mc Glone Suttner Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Mc Glone Suttner Wealth Management, Inc. with notifications on news.